Bai, Zongke
Yang, Peiwei
Yu, Fan
Li, Zhong
Yao, Zheng
Martinez, Jean
Li, Mengwei
Xu, Hanmei http://orcid.org/0000-0002-2648-8628
Article History
Received: 22 August 2021
Revised: 20 December 2021
Accepted: 12 January 2022
First Online: 5 April 2022
Competing interests
: The authors declare no competing interests.
: The Shanghai Mengchao Cancer Hospital (Shanghai, China) performed NK cell infusion, and their ethics committee (No.05, 2020, Medical Ethics Committee of Shanghai Mengchao Cancer Hospital) approved all protocols. All volunteers provided signed informed consent to obtain peripheral blood. Fresh blood was obtained from healthy volunteers after informed consent was provided, and the institutional review board of China Pharmaceutical University (Permit Number: SYXK2016-0011) approved the protocol. This study was performed in accordance with the Declaration of Helsinki.